CIK 1444043
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q1. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Health Care Equipment & Supplies | 32.63% | 5 |
| Pharmaceuticals & Biotechnology | 27.94% | 9 |
| Insurance | 14.56% | 2 |
| Unclassified | 10.21% | 3 |
| Food & Staples Retailing | 10.09% | 1 |
| Health Care Providers & Services | 3.23% | 2 |
| Professional Services | 1.33% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | ZBH | ZIMMER BIOMET HOLDINGS, INC. | Health Care | 12.71% |
| 2 | BAX | BAXTER INTERNATIONAL INC | Health Care | 12.02% |
| 3 | HUM | HUMANA INC | Financials | 10.22% |
| 4 | CVS | CVS HEALTH Corp | Consumer Staples | 10.09% |
| 5 | GMED | GLOBUS MEDICAL INC | Health Care | 6.58% |
| 6 | ICLR | ICON PLC | Unclassified | 6.08% |
| 7 | ASND | Ascendis Pharma A/S | Health Care | 6.01% |
| 8 | MRK | Merck & Co., Inc. | Health Care | 5.51% |
| 9 | PFE | PFIZER INC | Health Care | 5.06% |
| 10 | BMRN | BIOMARIN PHARMACEUTICAL INC | Health Care | 4.59% |
20/23 names classified · sector 89.8% of weight · industry 89.8% · mkt cap 83.8%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 89.8% of the book is sector-classified (unclassified names shown, never dropped).
Classified: 73.0% of book weight (11/22 names) · unclassified 27.0%: ICLR, ASND, , VTRS, BKD, MYGN, EVH, INGN, DNLI, ANAB +1 more. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| # | Security | Shares | Value | Weight | Δ QoQ |
|---|---|---|---|---|---|
| 1 | ZBHZIMMER BIOMET HOLDINGS INC | 1,000,000 | $91M | 12.7% | TRIM −56% |
| 2 | BAXBAXTER INTL INC | 2,850,000 | $86M | 12.0% | TRIM −50% |
| 3 | HUMHUMANA INC | 300,000 | $73M | 10.2% | TRIM −59% |
| 4 | CVSCVS HEALTH CORP | 1,050,000 | $72M | 10.1% | TRIM −53% |
| 5 | GMEDGLOBUS MED INC | 800,000 | $47M | 6.6% | TRIM −36% |
| 6 | ICLRICON PLC | 300,000 | $44M | 6.1% | NEW |
| 7 | ASNDASCENDIS PHARMA A/S | 250,000 | $43M | 6.0% | TRIM −29% |
| 8 | MRKMERCK & CO INC | 500,000 | $40M | 5.5% | NEW |
| 9 | PFEPFIZER INC | 1,500,000 | $36M | 5.1% | TRIM −40% |
| 10 | BMRNBIOMARIN PHARMACEUTICAL INC | 600,000 | $33M | 4.6% | ADD 20% |
| 11 | UNHUNITEDHEALTH GROUP INC | 100,000 | $31M | 4.3% | NEW |
| 12 | VTRSVIATRIS INC | 2,750,000 | $25M | 3.4% | TRIM −63% |
| 13 | BKDBROOKDALE SR LIVING INC | 2,150,000 | $15M | 2.1% | TRIM −66% |
| 14 | ZIMVIE INC | 1,600,000 | $15M | 2.1% | TRIM −15% |
| 15 | APELLIS PHARMACEUTICALS INC | 850,000 | $15M | 2.0% | NEW |
| 16 | MYGNMYRIAD GENETICS INC | 2,000,000 | $11M | 1.5% | TRIM −15% |
| 17 | EVHEVOLENT HEALTH INC | 850,000 | $10M | 1.3% | TRIM −72% |
| 18 | CONCONCENTRA GROUP HOLDINGS PAR | 400,000 | $8M | 1.1% | TRIM −75% |
| 19 | INGNINOGEN INC | 975,000 | $7M | 1.0% | HOLD |
| 20 | DNLIDENALI THERAPEUTICS INC | 400,000 | $6M | 0.8% | TRIM −68% |
| 21 | TBPHTHERAVANCE BIOPHARMA INC | 450,000 | $5M | 0.7% | TRIM −55% |
| 22 | ANABANAPTYSBIO INC | 125,000 | $3M | 0.4% | TRIM −83% |
| 23 | OSURORASURE TECHNOLOGIES INC | 900,000 | $3M | 0.4% | HOLD |
Where this firm's principals came from and which firms its alumni went on to found.
